Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;21(2):131-140.
doi: 10.1007/s10388-023-01039-3. Epub 2024 Jan 9.

Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients

Yong-Cheng Ye  1   2   3 , Yen-Po Wang  4   5   6   7 , Tien-En Chang  1   2   3 , Pei-Shan Wu  1   2   3 , I-Fang Hsin  1 , Ping-Hsien Chen  1   8 , Shyh-Kuan Tai  3   9 , Pen-Yuan Chu  3   9 , Ming-Chih Hou  1   2   3 , Ching-Liang Lu  1   2   10   3
Affiliations

Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients

Yong-Cheng Ye et al. Esophagus. 2024 Apr.

Abstract

Background: Esophageal squamous cell neoplasms (ESCNs) are common second primary tumors in patients with head and neck cancer. Image-enhanced endoscopy (IEE) with Lugol chromoendoscopy or magnifying narrow-band imaging both increase the detection of early ESCNs. No evidence-based ESCN surveillance program for head and neck cancer patients without a history of synchronous ESCNs exists. We aimed to evaluate the performance of an IEE surveillance program with magnifying narrow-band imaging endoscopy and Lugol chromoendoscopy.

Methods: From April 2016, we routinely used IEE with magnifying narrow-band imaging and Lugol chromoendoscopy to evaluate patients with head and neck cancer history. All patients who were negative for ESCNs at the first surveillance endoscopy and received at least 2 IEEs through December 2019 were included. Demographic profiles, clinical data, cancer characteristics, IEE results and pathology reports were analyzed.

Results: A total of 178 patients were included. Only 4 patients (2.2%) developed metachronous ESCNs during follow-up, all of whom received curative resection treatment. The interval for the development of metachronous ESCNs was 477 to 717 days. In multivariate Firth logistic regression and Kaplan‒Meier survival curve analysis, Lugol's voiding lesion type C had an increased risk of esophageal cancer development (adjusted odds ratio = 15.71; 95% confidence interval, 1.33-185.87, p = 0.029). Eight patients died during the study period, and none of them had metachronous ESCNs.

Conclusions: IEE with magnifying narrow-band imaging and Lugol chromoendoscopy is an effective surveillance program in head and neck cancer patients without a history of ESCNs. Annual surveillance can timely detect early ESCNs with low ESCN-related mortality.

Keywords: Esophageal squamous neoplasms; Head and neck cancer; Image-enhanced endoscopy; Lugol chromoendoscopy; Magnifying narrow-band imaging endoscopy.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. - DOI - PubMed
    1. Chung CS, Liao LJ, Wu CY, et al. Endoscopic screening for second primary tumors of the esophagus among head and neck cancer patients. Front Oncol. 2022;12: 906125. - DOI - PubMed - PMC
    1. Erkal HS, Mendenhall WM, Amdur RJ, et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol. 2001;19(5):1358–62. - DOI - PubMed
    1. Lee DH, Roh JL, Baek S, et al. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2013;149(4):579–86. - DOI - PubMed
    1. Wang WL, Lee CT, Lee YC, et al. Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck. 2011;33(1):77–81. - DOI - PubMed

MeSH terms

LinkOut - more resources